HEMISPHERX BIOPHARMA INC | Business Finance | Business Contracts

Description of Common Stock (Filed With SEC on March 31, 2021)

December 5, 2019 Security Agreement between the Company and Atlas Sciences, LLC (Filed With SEC on December 11, 2019)

Form of Pre-Funded Warrant (Filed With SEC on September 27, 2019)

Form of Non-Transferable Subscription Rights Certificate (Filed With SEC on February 6, 2019)

Description of Common Stock (Filed With SEC on March 30, 2020)

December 5, 2019 Secured Promissory Note from the Company to Atlas Sciences, LLC (Filed With SEC on December 11, 2019)

Form of Warrant (Filed With SEC on September 27, 2019)

Underwriting Agreement (Filed With SEC on September 24, 2019)

Form of Representatives Warrant (Filed With SEC on September 24, 2019)

Form of Warrant (Filed With SEC on September 6, 2019)

Form of Pre-Funded Warrant (Filed With SEC on September 6, 2019)

Form of Restricted Stock Award (Filed With SEC on August 26, 2019)

Salary Reduction and Restricted Stock Award Memo (Filed With SEC on August 26, 2019)

Note Purchase Agreement dated August 5, 2019 with Chicago Ventures Partners, L.P (Filed With SEC on August 14, 2019)

Security Agreement dated August 5, 2019 with Chicago Ventures Partners, L.P (Filed With SEC on August 14, 2019)

Warrant Agency Agreement with American Stock Transfer & Trust Company, LLC (Filed With SEC on March 8, 2019)

Revised Form of Warrant Certificate for Rights Offering (Filed With SEC on February 27, 2019)

Form of Warrant Agreement (Filed With SEC on February 6, 2019)

HEMISPHERX BIOPHARMA INC (42) | Business Finance (23)